CORAL XT - Open-label Extension Trial of the CORAL Trial

NCT02031432 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Neoplasms
Chronic Pain

Interventions

DRUG: Cebranopadol

Sponsor

Tris Pharma, Inc.